Business · 28/07/2026Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Cancer Clinical Trial Eligibility Criteria
Summary
The FDA has released a final guidance document outlining eligibility criteria for cancer clinical trials, including recommendations on washout periods and concomitant medications, to help industry, IRBs, and clinical investigators.
Original source language: Federal Register — Health and Human ServicesOpen original release →